{"ticker": {"uuid": "6e87b10d-64a7-4683-8403-426c76ff522a", "symbol": "TMCI", "name": "Treace Medical Concepts Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSE1TMmtwV0h4VjJJbV9pMDY1VGZIUE4td2xWcGZKZUNTSk8wYXJab3JZSUQzN3lrZ3Y3QWhqMHMzYlpTU0hOMHB0eTQtMF96Nk5rYnVVR2xQb2R3U0RadmdtTHJ4dnBiTGtMTXJNT2c5WUVlQzdadkd0ZWNiR21wbDdhd2thOTdxYUFuRlRJczZTOVFtMEo5TVFyT29YZUx2dl83eUVBaFkxMVJwbDU4Z3duUGticTUzWDZrd0FHNTZxbnVzOVNhRUt0ZjQ1NUtBY3hmR0U3WDl2d0JSbkM4Z2QtWTA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-16T12:58:41+00:00", "published_display": "16 Jul 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in June", "summary": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) experienced a significant 46.6% decline in short interest in June, bringing the total to 1.75 million shares or about 3.5% of its outstanding shares. Despite weak fundamentals, including a negative net margin and anticipated full-year l", "url": "https://www.marketbeat.com/instant-alerts/treace-medical-concepts-inc-nasdaqtmci-short-interest-down-466-in-june-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T13:45:17", "published_display": "15 Jul 2026 13:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)", "summary": "Johnson Fistel, PLLP is investigating potential breaches of fiduciary duty by officers and directors of Treace Medical Concepts, Inc. (TMCI) on behalf of long-term shareholders who held shares continuously since before May 8, 2023. The investigation focuses on alleged false and m", "url": "https://supplychaindigital.com/globenewswire/3326260", "source_name": "Supply Chain Digital", "published_at": "2026-07-14T08:12:39", "published_display": "14 Jul 2026 08:12", "sentiment": "negative", "sentiment_pct": 9, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Law firm investigates Treace Medical for alleged false statements affecting shareholders.", "summary": "Johnson Fistel, PLLP is investigating Treace Medical Concepts, Inc. on behalf of long-term shareholders for alleged breaches of fiduciary duty by its officers and directors. The investigation stems from allegations that Treace made false or misleading statements regarding its bus", "url": "https://pluang.com/en/news-feed/investigasi-johnson-fistel-terhadap-treace-medical-concepts-inc", "source_name": "Pluang", "published_at": "2026-07-13T14:10:25", "published_display": "13 Jul 2026 14:10", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors \u2013 Lead Plaintiff Deadline June 10, 2025", "summary": "Levi & Korsinsky LLP has announced a class action securities lawsuit against Treace Medical Concepts, Inc. (NASDAQ: TMCI) for alleged securities fraud between May 8, 2023, and May 7, 2024. The lawsuit claims that the company made false statements and/or concealed that competition", "url": "https://www.natlawreview.com/press-releases/tmci-lawsuit-alert-levi-korsinsky-notifies-treace-medical-concepts-inc-1", "source_name": "The National Law Review", "published_at": "2026-07-01T08:09:23", "published_display": "01 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI - Treace Medical Concepts Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its stock performance, key financial metrics, volatility data, and institutional/insider ownership. It covers various ratios, growth rates, and analyst recommendations, offering a", "url": "https://finviz.com/stock?t=TMCI&ta=1&p=d&ty=ocv&b=2&r=m6&ov=chain_date&e=2026-09-18", "source_name": "Finviz", "published_at": "2026-07-01T07:09:42", "published_display": "01 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI - Treace Medical Concepts Inc Earnings", "summary": "This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance metrics, insider and institutional ownership, and short i", "url": "https://finviz.com/stock?t=TMCI&ta=1&p=d&ty=ea&b=2&r=m1", "source_name": "Finviz", "published_at": "2026-07-01T07:09:42", "published_display": "01 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc.(NasdaqGS: TMCI) added to Russell Microcap Index", "summary": "Treace Medical Concepts, Inc. (NasdaqGS: TMCI) has been added to the Russell Microcap Index. This follows several adjustments to Russell indexes, where TMCI was concurrently dropped from other benchmarks including the Russell Small Cap Comp Growth, Russell 2500 Growth, and Russel", "url": "https://www.marketscreener.com/news/treace-medical-concepts-inc-nasdaqgs-tmci-added-to-russell-microcap-index-ce7f5fdedd89f020", "source_name": "marketscreener.com", "published_at": "2026-06-30T09:11:30", "published_display": "30 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "Treace Medical Concepts, Inc. (TMCI) has been removed from the Russell Small Cap Comp Growth Benchmark, as well as several other Russell indices including the Russell 2500 Growth Benchmark, Russell 2000 Index, Russell 2500 Index, and Russell 3000 Index. Concurrently, the company ", "url": "https://www.marketscreener.com/news/treace-medical-concepts-inc-nasdaqgs-tmci-dropped-from-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc8bf52c", "source_name": "marketscreener.com", "published_at": "2026-06-29T21:15:00", "published_display": "29 Jun 2026 21:15", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Treace Medical Concepts, Inc. (NASDAQ: TMCI). The firm encourages investors who purchased Treace Medical securities before May 8, 2023, and still hold them, to contact them to ", "url": "https://natlawreview.com/press-releases/treace-medical-concepts-inc-tmci-investigation-bronstein-gewirtz-grossman", "source_name": "The National Law Review", "published_at": "2026-06-28T18:40:59", "published_display": "28 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Investors - Lead Plaintiff Deadline on June 10, 2025", "summary": "Levi & Korsinsky has announced a lead plaintiff deadline of June 10, 2025, for investors of Treace Medical Concepts, Inc. (TMCI) who suffered losses due to alleged securities fraud. The class action lawsuit claims the company made false statements about competition impacting dema", "url": "https://natlawreview.com/press-releases/levi-korsinsky-notifies-treace-medical-concepts-inc-tmci-investors-lead", "source_name": "The National Law Review", "published_at": "2026-06-27T13:40:21", "published_display": "27 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "This article briefly presents the \"Price to earnings forward\" value for Treace Medical Concepts, Inc. (NASDAQ: TMCI). The content, likely from a financial data platform, shows the value for a specific period without providing further details or analysis.", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:11:13", "published_display": "25 Jun 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its First-Quarter Results", "summary": "This article states that analysts are updating their estimates for Treace Medical Concepts, Inc. (NASDAQ:TMCI) following the release of its first-quarter results. The content is missing, preventing a detailed summary of the company's performance or analyst reactions.", "url": "https://news.futunn.com/en/post/73030840/analysts-are-updating-their-treace-medical-concepts-inc-nasdaq-tmci", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-25T17:39:53", "published_display": "25 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "The article provides the enterprise value to revenue forward for Treace Medical Concepts, Inc. (NASDAQ: TMCI). It lists the current value, change, and percentage change for this financial metric. The content appears to be a snapshot from a financial data platform, likely TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T10:09:52", "published_display": "25 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Treace Medical Concepts, Inc. \u2013 BOATS:TMCI", "summary": "This page from TradingView displays the \"price to earnings forward\" metric for Treace Medical Concepts, Inc. (TMCI) under its Blue Ocean Alternative Trade System (BOATS) listing. It appears to be a financial data point for the company, accessible within a broader financial and ma", "url": "https://www.tradingview.com/symbols/BOATS-TMCI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T09:09:52", "published_display": "25 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "This article provides financial information for Treace Medical Concepts, Inc. (NASDAQ: TMCI), specifically focusing on its enterprise value to forward EBITDA. The content appears to be a stub or an incomplete data presentation page from TradingView, indicating financial metrics w", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T19:40:23", "published_display": "24 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Treace Medical Concepts Inc (TMCI), noting its current institutional shareholding score of 5.00, placing it 109th out of 204 in the Healthcare Equipment & Supplies industry. It highlights that the latest institutional sharehold", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/sentiment", "source_name": "TradingKey", "published_at": "2026-06-22T15:39:38", "published_display": "22 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary", "summary": "This article summarizes Treace Medical Concepts' (TMCI) presentation at the Sidoti Small-Cap Virtual Investor Conference. Key takeaways include the company's strategic focus on 3D bunion correction, expansion into new product lines, and positive financial performance with improve", "url": "https://quartr.com/events/treace-medical-concepts-tmci-sidoti-small-cap-virtual-investor-conference_ond1dLOf", "source_name": "Quartr", "published_at": "2026-06-20T04:39:50", "published_display": "20 Jun 2026 04:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q3 2024 earnings summary", "summary": "Treace Medical Concepts (TMCI) reported Q3 2024 revenue of $45.1 million, an 11% increase year-over-year, and a net loss of $15.4 million ($0.25 per share), an improvement from the prior year. The company launched the Nanoplasty 3D MIS system and is pursuing patent litigation. TM", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-q3-2024_ond173Co", "source_name": "Quartr", "published_at": "2026-06-19T19:41:04", "published_display": "19 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Proxy filing Summary", "summary": "Treace Medical Concepts (TMCI) released a summary of its proxy filing for the upcoming annual meeting on May 19, 2026. Key highlights from 2025 include the launch of new minimally invasive bunion correction systems, expansion into biologics, and $212.7 million in revenue. Shareho", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-proxy-filing_ond1rdYF", "source_name": "Quartr", "published_at": "2026-06-19T18:41:04", "published_display": "19 Jun 2026 18:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q2 2024 earnings summary", "summary": "Treace Medical Concepts (TMCI) reported Q2 2024 revenue of $44.5 million, marking a 6% year-over-year increase, driven by higher case volumes and new product adoption. Despite revenue growth, the company's net loss widened to $21.2 million due to increased operating expenses and ", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-q2-2024_ond1Wnnr", "source_name": "Quartr", "published_at": "2026-06-19T18:39:36", "published_display": "19 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) 2024 Truist Securities MedTech Conference Summary", "summary": "Treace Medical Concepts (TMCI) presented at the 2024 Truist Securities MedTech Conference, highlighting market evolution, growth opportunities, and strategic responses to increased competition. The company plans to launch two minimally invasive osteotomy platforms by late 2024 to", "url": "https://quartr.com/events/treace-medical-concepts-tmci-2024-truist-securities-medtech-conference_ond17k8q", "source_name": "Quartr", "published_at": "2026-06-19T01:39:37", "published_display": "19 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Announces First Surgical Case with the HyperPlate\u2122 XM Dynamic Compression Locking Implant System", "summary": "Treace Medical Concepts, Inc. announced the successful completion of the first surgical case using its new HyperPlate\u2122 XM Dynamic Compression Locking Implant system. This system, designed for midfoot and hindfoot fusion procedures, offers enhanced stability and dynamic compressio", "url": "https://markets.businessinsider.com/news/stocks/treace-announces-first-surgical-case-with-the-hyperplate-xm-dynamic-compression-locking-implant-system-1036259237", "source_name": "markets.businessinsider.com", "published_at": "2026-06-18T11:09:22", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace treats its first patient with HyperPlate XM foot implant", "summary": "Treace (Nasdaq: TMCI) has successfully completed the first surgical case using its new HyperPlate\u2122 XM Dynamic Compression Locking Implant, an extension of its SpeedPlate platform for midfoot and hindfoot fusion procedures and osteotomies. The titanium system features FastPitch lo", "url": "https://www.stocktitan.net/news/TMCI/treace-announces-first-surgical-case-with-the-hyper-plate-tm-xm-04sq2dzg7ieu.html", "source_name": "Stock Titan", "published_at": "2026-06-18T11:09:22", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution \u2014 TradingKey", "summary": "The article provides a snapshot of Treace Medical Concepts Inc. (TMCI) stock performance, showing a slight increase of 1.39%. It highlights the company's market capitalization but notes that relevant data regarding revenue breakdown by business segments and regions has not yet be", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:22", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Treace Medical Concepts Inc (TMCI), noting its current earnings forecast score is 6.00 and ranks 169 out of 203 in the Healthcare Equipment & Supplies industry. Analysts have a \"Hold\" rating on the stock with an average price target o", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:04", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Treace Medical Concepts Inc (TMCI), listing major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several recent quarters, and recent shareholder activities includi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:09:22", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis of Treace Medical Concepts Inc (TMCI), noting its current valuation score of 8.19, which ranks it 109 out of 203 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of -4.31, which is significant", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T00:40:12", "published_display": "17 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) CEO boosts direct stake with June share buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQLUZzRVpHNW5teVhBb3Q3QXVPT1dLQThLNzJXY1YzR2tObUlkT0J6bjlORDcxb0FYc2FkZFp1TXBuWUM4RTdOazYyLWM3c0VpSVM5dmJnMHpuQVV6Rl9XNlg0M2U2QWJORE4wZkdCQWpVSmVROWJSMjVONEhTWmtPUWtNaGhZbFFwQ294Q3R5ZTBpZWVQVVc4andRSEI0dThvNFljZWp2YkxKdjBDNUl6dHNaSjBqbVNHRkFnazlKM3U2b3ptR2prTE56SQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace to Present at the Sidoti Small Cap Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/treace-present-sidoti-small-cap-200500905.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T20:05:00+00:00", "published_display": "11 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOTy01bFZ2eHNfMlMyWG5vZVgtSTliUjgyT2RFbXJqYWl6OTE5Vlo3QkZUU2FJRlRidXZGSS1lOU1IMTJkZHJKY3JVd0JOVzhHcXpKVE1EWlVXSzNsLWNVVmJIcmE0bFN0M1RlX1Z0bkljM1pvWVRkTVcxR0w2MEJ0Z3JMTGtmN2ZwY25aV2hnaFdfdkhJSnlPc2FuU2dQTnFwdXRLcjRJNWo2bllEdVQwQ3NmN29zZ2ZLR0JndHFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts CEO John T. Treace buys $210,967 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNYVNOUkI4YlNsZUVmMjNJU0hJMGk4V2o3X2FEREM4V085aWFzNS1IelphLVNJNW1ibXBTQzZGbjNwa1haQkxVUEZ1LW5ETW0tcnY1Y2lTOV9zRWZSMnpVT1hucTVweDZrdk1uZzdSUjFOYXBaTE5CUWs0TzdIS0xlQ1huSnlGZExpMm9NUGx4d3Jha3dDVVh2MnVsdFZadDhwcDREd3V5ci01N2E3d2M5MDhNVzhWVHVBUGQ3S25hTmR6TWtxWEE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace to showcase bunion surgery tech at Sidoti Small Cap Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNM055dDNsMWNVUkRWNm5ka0hYQWN1NnV1RXpaaXFKd0hiRGZhNGZtN0o4WDl1b3NYT3ZENGZuc1h3QXNSUUdOREZiNHJEcVBvV0ViNG0wN19aY2Z4czdtWFBXaENtdUxFeHpWc2UzeWVBaXRrb05YdDhmMFBtZWxpWGswWmJ6N0JUblBVNjJWdlpuTE5SR0NpNGpXaG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/754b24ad-220d-37ad-8f5c-6d20c22ff6a4/treace-medical-%28tmci%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:35:45+00:00", "published_display": "01 Jun 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/2fcef0a1-fc0e-3838-9e45-78a5d6227f9e/treace-medical-%28tmci%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:34:55+00:00", "published_display": "01 Jun 2026 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/treace-medical-concepts-insider-bought-204004534.html", "source_name": "MT Newswires", "published_at": "2026-05-28T20:40:04+00:00", "published_display": "28 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPVl9UUlBTVnNnMDZOOVdKMWstbUVMMWtPWUJRZFJfV1hXeHJhQmFGcHhpdzRMcFNqaHZNR1ROb3BwcXc1UXg4Q3VNak14Z2loWjJIaFphQTZDNS1LN1BBcnRVbWswanYzN2xaRm1PUnViY1NfWWVqcE5uTWgwYnZpMUYyQjZfMmxrNmpwWVVCa1FaaE9sSTZLaWVIWUJQQ2VocnhPLUt3MlhoaUYtS2poU3l6Y0I5Y1BXT3BPNHdn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/treace-medical-concepts-insider-bought-213819410.html", "source_name": "MT Newswires", "published_at": "2026-05-14T21:38:19+00:00", "published_display": "14 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQdmVaTW9FZFVzLW5hQ2hfRjdTSHp1NlpKTkQ4VWV3Y3c1b2lwSE1wVURIQWliOW1WSHAyaWhGb1J4c1pKN3Y5UjNKLTZsWjBQRU1YVWVHNkJsbGxVbm84SUlkYkxuMHVsNjBEdWMyU1FDMGVXcm4xdHo3bzB2WmxnZnBsWmhiQk5iU3p4N0N5eGNwTGpxTk8zdGV4aEFVd1FCMXdzbE9TQm5td3l6dHd2QnlFLXVMNVlrQUpUZVREdWdpSE9Qd2QzQjRsSjl0RXZacXEwQ3FHVFVCSlHSAeABQVVfeXFMT2pORlZaR1NlY2stZjlUTlVkSkp4aXlUMVd0WlVjQmpaUDVLVklfempJUVdESHJMd3RFaV9Gek9DU2xXdTc1T2liZWV5RUhKZU9OZGZucG1FQjNiODNfZ2NRbGhqcmpldlNwUTJrUkNVTExTd0EzWktnb3BsZnA0MDZtU1JjamhvUm5ZVHlsdGZwQ1V6aEpQMnlZU3JBRnRBQWtSdG5aT2VPczN6VVhZTER3azFELWZMbnVJRjJfYWlFVmlxU0gyMnJsNzl0cEpjR2RaYV9xQmNHaVNYUEdhT2w?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcWtwLWFrem9rdEJlUTlSRDdkd3RyemNKZi1iQ2JRbFV5QmR0Y0hmMTVNeFU1MnI4YTA4N21OR3cxYkFNMDluTTlpeGQ5ZXJEa2kxb284TG40MmtGOERTRlo1WkFZSmRiNnVTUmZCZVV1cFBDMHFhcFBZc0lyTEtyYkV4OWZ1MGkzOUQyM19ELVRzaGhwcGdrTjI1NnRVSU5paDFZRFJUNEI?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPVm5rWW1DUnRaQ1I1NmFQYjZfN3poZzg4WGkxaU1Ub0pPeTZUVkVlb0RaZDU5TG1rVnZpMWxCalpmYVhOdnBMQWpEaWY3dHF1QmgzOTVFNG0yOE43WTNMQk9PYkhOVjBXRHZlRGxzeTRRRFFLc0hreThrVHpzVm1xX19qLU5qZWc4Q3JHUHp0VGd3NjhfUlk2YTdReHhPMjh6?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPb2FBbG81OHVLYldzc0lRMzVhVUthWDdhcVhhWklldHFIODZxS3RqNzJKTFFnUUhQVHQ4TWswVW1ZLUwzalBDYnlPampOVWJiQWtxc1BFU2h0NTBmUUNMWVlzMG5LTTYwSkIzSW9ubThIeFhiTV9iNi1ndmhkeExrZ1RESnpiWjFFT1RtM0RoOWFLX0tmZWViNWJJYlY2djljOHlVVVZpRUpZdzg?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNRmg3U0ZDV2dialhGbkIxOFE1bkdmZTNkYnJVMEw3ZGVVSjB1UG9fc0l3dFU3YklEUS1NakhFVlBuNGg0aE1Yc182QmlST3prRHZTWWU4eXFweFl3MWlvejdjeUhCTUdxeFhBTmFZZFNYYWdEeVdWOEhGZlZQMWtSZUVjRlNMNS1JQk1jaXZpV3ZqTW5CSFZMZkVHa0cwV0JPdDRlQ1BR?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNSE1TMmtwV0h4VjJJbV9pMDY1VGZIUE4td2xWcGZKZUNTSk8wYXJab3JZSUQzN3lrZ3Y3QWhqMHMzYlpTU0hOMHB0eTQtMF96Nk5rYnVVR2xQb2R3U0RadmdtTHJ4dnBiTGtMTXJNT2c5WUVlQzdadkd0ZWNiR21wbDdhd2thOTdxYUFuRlRJczZTOVFtMEo5TVFyT29YZUx2dl83eUVBaFkxMVJwbDU4Z3duUGticTUzWDZrd0FHNTZxbnVzOVNhRUt0ZjQ1NUtBY3hmR0U3WDl2d0JSbkM4Z2QtWTA?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-16T12:58:41+00:00", "published_display": "16 Jul 2026 12:58", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) Short Interest Down 46.6% in June", "summary": "Treace Medical Concepts, Inc. (NASDAQ:TMCI) experienced a significant 46.6% decline in short interest in June, bringing the total to 1.75 million shares or about 3.5% of its outstanding shares. Despite weak fundamentals, including a negative net margin and anticipated full-year l", "url": "https://www.marketbeat.com/instant-alerts/treace-medical-concepts-inc-nasdaqtmci-short-interest-down-466-in-june-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T13:45:17", "published_display": "15 Jul 2026 13:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Treace Medical Concepts, Inc. (TMCI)", "summary": "Johnson Fistel, PLLP is investigating potential breaches of fiduciary duty by officers and directors of Treace Medical Concepts, Inc. (TMCI) on behalf of long-term shareholders who held shares continuously since before May 8, 2023. The investigation focuses on alleged false and m", "url": "https://supplychaindigital.com/globenewswire/3326260", "source_name": "Supply Chain Digital", "published_at": "2026-07-14T08:12:39", "published_display": "14 Jul 2026 08:12", "sentiment": "negative", "sentiment_pct": 9, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Law firm investigates Treace Medical for alleged false statements affecting shareholders.", "summary": "Johnson Fistel, PLLP is investigating Treace Medical Concepts, Inc. on behalf of long-term shareholders for alleged breaches of fiduciary duty by its officers and directors. The investigation stems from allegations that Treace made false or misleading statements regarding its bus", "url": "https://pluang.com/en/news-feed/investigasi-johnson-fistel-terhadap-treace-medical-concepts-inc", "source_name": "Pluang", "published_at": "2026-07-13T14:10:25", "published_display": "13 Jul 2026 14:10", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors \u2013 Lead Plaintiff Deadline June 10, 2025", "summary": "Levi & Korsinsky LLP has announced a class action securities lawsuit against Treace Medical Concepts, Inc. (NASDAQ: TMCI) for alleged securities fraud between May 8, 2023, and May 7, 2024. The lawsuit claims that the company made false statements and/or concealed that competition", "url": "https://www.natlawreview.com/press-releases/tmci-lawsuit-alert-levi-korsinsky-notifies-treace-medical-concepts-inc-1", "source_name": "The National Law Review", "published_at": "2026-07-01T08:09:23", "published_display": "01 Jul 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI - Treace Medical Concepts Inc Volatility & Greeks", "summary": "This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its stock performance, key financial metrics, volatility data, and institutional/insider ownership. It covers various ratios, growth rates, and analyst recommendations, offering a", "url": "https://finviz.com/stock?t=TMCI&ta=1&p=d&ty=ocv&b=2&r=m6&ov=chain_date&e=2026-09-18", "source_name": "Finviz", "published_at": "2026-07-01T07:09:42", "published_display": "01 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "TMCI - Treace Medical Concepts Inc Earnings", "summary": "This article provides a detailed financial overview of Treace Medical Concepts Inc (TMCI), including its last closing price, market capitalization, income, sales, and various financial ratios. It also lists key performance metrics, insider and institutional ownership, and short i", "url": "https://finviz.com/stock?t=TMCI&ta=1&p=d&ty=ea&b=2&r=m1", "source_name": "Finviz", "published_at": "2026-07-01T07:09:42", "published_display": "01 Jul 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc.(NasdaqGS: TMCI) added to Russell Microcap Index", "summary": "Treace Medical Concepts, Inc. (NasdaqGS: TMCI) has been added to the Russell Microcap Index. This follows several adjustments to Russell indexes, where TMCI was concurrently dropped from other benchmarks including the Russell Small Cap Comp Growth, Russell 2500 Growth, and Russel", "url": "https://www.marketscreener.com/news/treace-medical-concepts-inc-nasdaqgs-tmci-added-to-russell-microcap-index-ce7f5fdedd89f020", "source_name": "marketscreener.com", "published_at": "2026-06-30T09:11:30", "published_display": "30 Jun 2026 09:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell Small Cap Comp Growth Benchmark", "summary": "Treace Medical Concepts, Inc. (TMCI) has been removed from the Russell Small Cap Comp Growth Benchmark, as well as several other Russell indices including the Russell 2500 Growth Benchmark, Russell 2000 Index, Russell 2500 Index, and Russell 3000 Index. Concurrently, the company ", "url": "https://www.marketscreener.com/news/treace-medical-concepts-inc-nasdaqgs-tmci-dropped-from-russell-small-cap-comp-growth-benchmark-ce7f5fdfdc8bf52c", "source_name": "marketscreener.com", "published_at": "2026-06-29T21:15:00", "published_display": "29 Jun 2026 21:15", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Treace Medical Concepts, Inc. (NASDAQ: TMCI). The firm encourages investors who purchased Treace Medical securities before May 8, 2023, and still hold them, to contact them to ", "url": "https://natlawreview.com/press-releases/treace-medical-concepts-inc-tmci-investigation-bronstein-gewirtz-grossman", "source_name": "The National Law Review", "published_at": "2026-06-28T18:40:59", "published_display": "28 Jun 2026 18:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Investors - Lead Plaintiff Deadline on June 10, 2025", "summary": "Levi & Korsinsky has announced a lead plaintiff deadline of June 10, 2025, for investors of Treace Medical Concepts, Inc. (TMCI) who suffered losses due to alleged securities fraud. The class action lawsuit claims the company made false statements about competition impacting dema", "url": "https://natlawreview.com/press-releases/levi-korsinsky-notifies-treace-medical-concepts-inc-tmci-investors-lead", "source_name": "The National Law Review", "published_at": "2026-06-27T13:40:21", "published_display": "27 Jun 2026 13:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "This article briefly presents the \"Price to earnings forward\" value for Treace Medical Concepts, Inc. (NASDAQ: TMCI). The content, likely from a financial data platform, shows the value for a specific period without providing further details or analysis.", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T19:11:13", "published_display": "25 Jun 2026 19:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its First-Quarter Results", "summary": "This article states that analysts are updating their estimates for Treace Medical Concepts, Inc. (NASDAQ:TMCI) following the release of its first-quarter results. The content is missing, preventing a detailed summary of the company's performance or analyst reactions.", "url": "https://news.futunn.com/en/post/73030840/analysts-are-updating-their-treace-medical-concepts-inc-nasdaq-tmci", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-06-25T17:39:53", "published_display": "25 Jun 2026 17:39", "sentiment": "positive", "sentiment_pct": 59, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "The article provides the enterprise value to revenue forward for Treace Medical Concepts, Inc. (NASDAQ: TMCI). It lists the current value, change, and percentage change for this financial metric. The content appears to be a snapshot from a financial data platform, likely TradingV", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T10:09:52", "published_display": "25 Jun 2026 10:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Treace Medical Concepts, Inc. \u2013 BOATS:TMCI", "summary": "This page from TradingView displays the \"price to earnings forward\" metric for Treace Medical Concepts, Inc. (TMCI) under its Blue Ocean Alternative Trade System (BOATS) listing. It appears to be a financial data point for the company, accessible within a broader financial and ma", "url": "https://www.tradingview.com/symbols/BOATS-TMCI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T09:09:52", "published_display": "25 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPZ3VmWDdGZC04R2RXUUJZTHJqVlJrdnhJYy1LaEJkcHBaWi1sWXdoWS1oLWFlVUQxdFNOQlNDdzhaTHJtMGRkX3pHc1pWbGp0bENwY1h6TlpvWVRWWmJxODh4emhGVDBFajd0VWNmUGNVcnN1SDBXRG9jZFVDa2M4MGFCVFhxbGN0ZXZqSTV2SUE1S3JjMTRnQlBiSnVmR0lv?oc=5", "source_name": "Market source", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Treace Medical Concepts, Inc. \u2013 NASDAQ:TMCI", "summary": "This article provides financial information for Treace Medical Concepts, Inc. (NASDAQ: TMCI), specifically focusing on its enterprise value to forward EBITDA. The content appears to be a stub or an incomplete data presentation page from TradingView, indicating financial metrics w", "url": "https://www.tradingview.com/symbols/NASDAQ-TMCI/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-24T19:40:23", "published_display": "24 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Treace Medical Concepts Inc (TMCI), noting its current institutional shareholding score of 5.00, placing it 109th out of 204 in the Healthcare Equipment & Supplies industry. It highlights that the latest institutional sharehold", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/sentiment", "source_name": "TradingKey", "published_at": "2026-06-22T15:39:38", "published_display": "22 Jun 2026 15:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Undervalued Medical-Devices Stock Is Poised for a Rebound", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPN1g2RjVsUTVvTmdXRTdJMTRpVTlOQnZIbm9hTWJDdkRaeVpINjFqbXpDUVFpMVdYMExyR2VQQVNpZ3p0V2F1SVJMelpJZWk1bExvb0dYWnJ4VVJJRURseEVQVVZwNnRZREZiQzlFTHlhSHFadGdXRmpxbXA2XzBMNA?oc=5", "source_name": "Barron's", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary", "summary": "This article summarizes Treace Medical Concepts' (TMCI) presentation at the Sidoti Small-Cap Virtual Investor Conference. Key takeaways include the company's strategic focus on 3D bunion correction, expansion into new product lines, and positive financial performance with improve", "url": "https://quartr.com/events/treace-medical-concepts-tmci-sidoti-small-cap-virtual-investor-conference_ond1dLOf", "source_name": "Quartr", "published_at": "2026-06-20T04:39:50", "published_display": "20 Jun 2026 04:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q3 2024 earnings summary", "summary": "Treace Medical Concepts (TMCI) reported Q3 2024 revenue of $45.1 million, an 11% increase year-over-year, and a net loss of $15.4 million ($0.25 per share), an improvement from the prior year. The company launched the Nanoplasty 3D MIS system and is pursuing patent litigation. TM", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-q3-2024_ond173Co", "source_name": "Quartr", "published_at": "2026-06-19T19:41:04", "published_display": "19 Jun 2026 19:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Proxy filing Summary", "summary": "Treace Medical Concepts (TMCI) released a summary of its proxy filing for the upcoming annual meeting on May 19, 2026. Key highlights from 2025 include the launch of new minimally invasive bunion correction systems, expansion into biologics, and $212.7 million in revenue. Shareho", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-proxy-filing_ond1rdYF", "source_name": "Quartr", "published_at": "2026-06-19T18:41:04", "published_display": "19 Jun 2026 18:41", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q2 2024 earnings summary", "summary": "Treace Medical Concepts (TMCI) reported Q2 2024 revenue of $44.5 million, marking a 6% year-over-year increase, driven by higher case volumes and new product adoption. Despite revenue growth, the company's net loss widened to $21.2 million due to increased operating expenses and ", "url": "https://quartr.com/events/treace-medical-concepts-inc-tmci-q2-2024_ond1Wnnr", "source_name": "Quartr", "published_at": "2026-06-19T18:39:36", "published_display": "19 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) 2024 Truist Securities MedTech Conference Summary", "summary": "Treace Medical Concepts (TMCI) presented at the 2024 Truist Securities MedTech Conference, highlighting market evolution, growth opportunities, and strategic responses to increased competition. The company plans to launch two minimally invasive osteotomy platforms by late 2024 to", "url": "https://quartr.com/events/treace-medical-concepts-tmci-2024-truist-securities-medtech-conference_ond17k8q", "source_name": "Quartr", "published_at": "2026-06-19T01:39:37", "published_display": "19 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Announces First Surgical Case with the HyperPlate\u2122 XM Dynamic Compression Locking Implant System", "summary": "Treace Medical Concepts, Inc. announced the successful completion of the first surgical case using its new HyperPlate\u2122 XM Dynamic Compression Locking Implant system. This system, designed for midfoot and hindfoot fusion procedures, offers enhanced stability and dynamic compressio", "url": "https://markets.businessinsider.com/news/stocks/treace-announces-first-surgical-case-with-the-hyperplate-xm-dynamic-compression-locking-implant-system-1036259237", "source_name": "markets.businessinsider.com", "published_at": "2026-06-18T11:09:22", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace treats its first patient with HyperPlate XM foot implant", "summary": "Treace (Nasdaq: TMCI) has successfully completed the first surgical case using its new HyperPlate\u2122 XM Dynamic Compression Locking Implant, an extension of its SpeedPlate platform for midfoot and hindfoot fusion procedures and osteotomies. The titanium system features FastPitch lo", "url": "https://www.stocktitan.net/news/TMCI/treace-announces-first-surgical-case-with-the-hyper-plate-tm-xm-04sq2dzg7ieu.html", "source_name": "Stock Titan", "published_at": "2026-06-18T11:09:22", "published_display": "18 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution \u2014 TradingKey", "summary": "The article provides a snapshot of Treace Medical Concepts Inc. (TMCI) stock performance, showing a slight increase of 1.39%. It highlights the company's market capitalization but notes that relevant data regarding revenue breakdown by business segments and regions has not yet be", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T09:09:22", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Treace Medical Concepts Inc (TMCI), noting its current earnings forecast score is 6.00 and ranks 169 out of 203 in the Healthcare Equipment & Supplies industry. Analysts have a \"Hold\" rating on the stock with an average price target o", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T02:39:04", "published_display": "18 Jun 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Treace Medical Concepts Inc (TMCI), listing major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several recent quarters, and recent shareholder activities includi", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T01:09:22", "published_display": "18 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Inc (TMCI) Valuation: PE, PB & Fair Value Analysis", "summary": "The article provides a valuation analysis of Treace Medical Concepts Inc (TMCI), noting its current valuation score of 8.19, which ranks it 109 out of 203 in the Healthcare Equipment & Supplies industry. It highlights the company's current P/E ratio of -4.31, which is significant", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-tmci/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T00:40:12", "published_display": "17 Jun 2026 00:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) CEO boosts direct stake with June share buys", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQLUZzRVpHNW5teVhBb3Q3QXVPT1dLQThLNzJXY1YzR2tObUlkT0J6bjlORDcxb0FYc2FkZFp1TXBuWUM4RTdOazYyLWM3c0VpSVM5dmJnMHpuQVV6Rl9XNlg0M2U2QWJORE4wZkdCQWpVSmVROWJSMjVONEhTWmtPUWtNaGhZbFFwQ294Q3R5ZTBpZWVQVVc4andRSEI0dThvNFljZWp2YkxKdjBDNUl6dHNaSjBqbVNHRkFnazlKM3U2b3ptR2prTE56SQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace to Present at the Sidoti Small Cap Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/treace-present-sidoti-small-cap-200500905.html", "source_name": "GlobeNewswire", "published_at": "2026-06-11T20:05:00+00:00", "published_display": "11 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxOTy01bFZ2eHNfMlMyWG5vZVgtSTliUjgyT2RFbXJqYWl6OTE5Vlo3QkZUU2FJRlRidXZGSS1lOU1IMTJkZHJKY3JVd0JOVzhHcXpKVE1EWlVXSzNsLWNVVmJIcmE0bFN0M1RlX1Z0bkljM1pvWVRkTVcxR0w2MEJ0Z3JMTGtmN2ZwY25aV2hnaFdfdkhJSnlPc2FuU2dQTnFwdXRLcjRJNWo2bllEdVQwQ3NmN29zZ2ZLR0JndHFR?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts CEO John T. Treace buys $210,967 in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNYVNOUkI4YlNsZUVmMjNJU0hJMGk4V2o3X2FEREM4V085aWFzNS1IelphLVNJNW1ibXBTQzZGbjNwa1haQkxVUEZ1LW5ETW0tcnY1Y2lTOV9zRWZSMnpVT1hucTVweDZrdk1uZzdSUjFOYXBaTE5CUWs0TzdIS0xlQ1huSnlGZExpMm9NUGx4d3Jha3dDVVh2MnVsdFZadDhwcDREd3V5ci01N2E3d2M5MDhNVzhWVHVBUGQ3S25hTmR6TWtxWEE?oc=5", "source_name": "Investing.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace to showcase bunion surgery tech at Sidoti Small Cap Conference", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNM055dDNsMWNVUkRWNm5ka0hYQWN1NnV1RXpaaXFKd0hiRGZhNGZtN0o4WDl1b3NYT3ZENGZuc1h3QXNSUUdOREZiNHJEcVBvV0ViNG0wN19aY2Z4czdtWFBXaENtdUxFeHpWc2UzeWVBaXRrb05YdDhmMFBtZWxpWGswWmJ6N0JUblBVNjJWdlpuTE5SR0NpNGpXaG0?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQRWNsVUM3aGV5UmJHYUowOWtNRU11RzZSalpyampRQ3ZQTlBNV05zSHo4MTJJS0JqTV92LWV3MUdXWkRIckNNZi1aeVg1TmtKNFpoS3g5dTBXRW1BZXRMWGo1SVl2NjNaQ2NSNV90V0MtMzBEQndVclZzUUVXbi1FU0lyU0FndlAwaXNfUVpOTXBEZWQtQVpmanRoU0JjLWxlakFJSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) Q4 2025 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/754b24ad-220d-37ad-8f5c-6d20c22ff6a4/treace-medical-%28tmci%29-q4-2025.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:35:45+00:00", "published_display": "01 Jun 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical (TMCI) Q1 2026 Earnings Transcript", "summary": "", "url": "https://finance.yahoo.com/m/2fcef0a1-fc0e-3838-9e45-78a5d6227f9e/treace-medical-%28tmci%29-q1-2026.html", "source_name": "Motley Fool", "published_at": "2026-06-01T17:34:55+00:00", "published_display": "01 Jun 2026 17:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & Supplies - Diversified Stocks In Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQV2pTUXRCTjY5SmdHMUhoekd1YmdUMW44R1VVYVlZZzh6QzB1VDZqSzJXT1RLOWpZeE16cGVfaVU3bUFsZ0g5OUkyRlpmQjUxUGw0eDAyb3oySURyM2taYm5qeWZRSzJHNmpLT3VSV3RNS3M3X2ZldWZNRGM4My1QYnNTRVI5WHRybDhfVll4OVdJTFpZUEpNdUZtRTVHVC1ORWFpanRUZmI1bTE0?oc=5", "source_name": "Market source", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/treace-medical-concepts-insider-bought-204004534.html", "source_name": "MT Newswires", "published_at": "2026-05-28T20:40:04+00:00", "published_display": "28 May 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPVl9UUlBTVnNnMDZOOVdKMWstbUVMMWtPWUJRZFJfV1hXeHJhQmFGcHhpdzRMcFNqaHZNR1ROb3BwcXc1UXg4Q3VNak14Z2loWjJIaFphQTZDNS1LN1BBcnRVbWswanYzN2xaRm1PUnViY1NfWWVqcE5uTWgwYnZpMUYyQjZfMmxrNmpwWVVCa1FaaE9sSTZLaWVIWUJQQ2VocnhPLUt3MlhoaUYtS2poU3l6Y0I5Y1BXT3BPNHdn?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE)", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNMTBnNnM2WGg4UWl4LXNNdUdWLVozU3ptQlRZQTk2SFFsOEZTLTVlbU5tNnhSTVRXX3RYczQ5b2hCR254bS1QYmZqV2JfdVFYTEx2U0hFeW1VREwybmRDWEE3MEpSWldySDJNTHFXbWcta2tNY0cwM0hVWld5VnVOWE1zY1VNQS1wQkIyZHN5a0dRNktDdnBvaTcyY3RKa292aThMTmNGeUpUUVU1Unhr?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPUFI2R08xV3JsZHYxbnFGcmk1Q3prRzBQVVlJNk5NTFlYOXBaczlzZE1PREIxb0loeUNQeUw3QWczNUowYXlEOU1KY1dTY2gybUQ5OEM0Z3Z2TlNleUVIRWJMc0VqZTdZcnVOZ2JBeUpIeFNCVjk3SVYxTmc5SG1RTjBHY2l3QkdxX09lZkpMekpYOElqQmJHc0dHUm8tVzJzSFZRaUdZZzNodTdyRjZz?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts Insider Bought Shares Worth $375,505, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/treace-medical-concepts-insider-bought-213819410.html", "source_name": "MT Newswires", "published_at": "2026-05-14T21:38:19+00:00", "published_display": "14 May 2026 21:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Q4 Loss Narrowing To US$0.15 EPS Tests Bearish Narratives", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxQdmVaTW9FZFVzLW5hQ2hfRjdTSHp1NlpKTkQ4VWV3Y3c1b2lwSE1wVURIQWliOW1WSHAyaWhGb1J4c1pKN3Y5UjNKLTZsWjBQRU1YVWVHNkJsbGxVbm84SUlkYkxuMHVsNjBEdWMyU1FDMGVXcm4xdHo3bzB2WmxnZnBsWmhiQk5iU3p4N0N5eGNwTGpxTk8zdGV4aEFVd1FCMXdzbE9TQm5td3l6dHd2QnlFLXVMNVlrQUpUZVREdWdpSE9Qd2QzQjRsSjl0RXZacXEwQ3FHVFVCSlHSAeABQVVfeXFMT2pORlZaR1NlY2stZjlUTlVkSkp4aXlUMVd0WlVjQmpaUDVLVklfempJUVdESHJMd3RFaV9Gek9DU2xXdTc1T2liZWV5RUhKZU9OZGZucG1FQjNiODNfZ2NRbGhqcmpldlNwUTJrUkNVTExTd0EzWktnb3BsZnA0MDZtU1JjamhvUm5ZVHlsdGZwQ1V6aEpQMnlZU3JBRnRBQWtSdG5aT2VPczN6VVhZTER3azFELWZMbnVJRjJfYWlFVmlxU0gyMnJsNzl0cEpjR2RaYV9xQmNHaVNYUEdhT2w?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNcWtwLWFrem9rdEJlUTlSRDdkd3RyemNKZi1iQ2JRbFV5QmR0Y0hmMTVNeFU1MnI4YTA4N21OR3cxYkFNMDluTTlpeGQ5ZXJEa2kxb284TG40MmtGOERTRlo1WkFZSmRiNnVTUmZCZVV1cFBDMHFhcFBZc0lyTEtyYkV4OWZ1MGkzOUQyM19ELVRzaGhwcGdrTjI1NnRVSU5paDFZRFJUNEI?oc=5", "source_name": "Market source", "published_at": "2026-05-08T07:00:00+00:00", "published_display": "08 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst Expectations", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPVm5rWW1DUnRaQ1I1NmFQYjZfN3poZzg4WGkxaU1Ub0pPeTZUVkVlb0RaZDU5TG1rVnZpMWxCalpmYVhOdnBMQWpEaWY3dHF1QmgzOTVFNG0yOE43WTNMQk9PYkhOVjBXRHZlRGxzeTRRRFFLc0hreThrVHpzVm1xX19qLU5qZWc4Q3JHUHp0VGd3NjhfUlk2YTdReHhPMjh6?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product Plans", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPb2FBbG81OHVLYldzc0lRMzVhVUthWDdhcVhhWklldHFIODZxS3RqNzJKTFFnUUhQVHQ4TWswVW1ZLUwzalBDYnlPampOVWJiQWtxc1BFU2h0NTBmUUNMWVlzMG5LTTYwSkIzSW9ubThIeFhiTV9iNi1ndmhkeExrZ1RESnpiWjFFT1RtM0RoOWFLX0tmZWViNWJJYlY2djljOHlVVVZpRUpZdzg?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOd1pNRFRBVUF2RG5RNWNhSVJaWFM5aUFRVF9xSF8zVHVMcVBoSXdaRXJrbV8wLUFOS2tHOHIzZEhZSF9rZ2dVbVNIOEdEbE9GMmpsMEtIUE9OTGRjcUlyVnNSa2FyX3hjcmF2YTNDOGQ1UDVjMHI4ak44bUl1bnVoQ3VfSjZGMXR5T19xOWkzaUtSZ2NiMF80bUtvVWU?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Story Is Shifting For Treace Medical Concepts (TMCI) After Analyst Target Resets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNRmg3U0ZDV2dialhGbkIxOFE1bkdmZTNkYnJVMEw3ZGVVSjB1UG9fc0l3dFU3YklEUS1NakhFVlBuNGg0aE1Yc182QmlST3prRHZTWWU4eXFweFl3MWlvejdjeUhCTUdxeFhBTmFZZFNYYWdEeVdWOEhGZlZQMWtSZUVjRlNMNS1JQk1jaXZpV3ZqTW5CSFZMZkVHa0cwV0JPdDRlQ1BR?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 103, "total_relevant": 69, "sentiment_summary": {"positive": 7, "negative": 7, "neutral": 55, "score": 50, "total": 69, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 16.85, "count": 30}, {"event": "earnings", "label": "Earnings", "weight": 14.85, "count": 27}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 4.32, "latest_week": "2026-07-10", "one_week_move": 2.6, "four_week_move": 6.4, "twelve_week_move": 122.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.426684, "market_dynamics_buy_signal": false, "relative_strength": -4.730308, "fair_value_gap": -42.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 49.0566, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.6% over one week, +6.4% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 18}, {"label": "TradingKey", "count": 5}, {"label": "Quartr", "count": 5}, {"label": "Stock Titan", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "marketscreener.com", "count": 3}, {"label": "The National Law Review", "count": 3}, {"label": "Finviz", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 69}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 30}, {"label": "Earnings", "count": 27}, {"label": "Analyst action", "count": 5}, {"label": "Regulatory and legal", "count": 5}, {"label": "Deals and strategy", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "69", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+2.6% over one week, +6.4% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Truist Securities Adjusts Price Target on Treace Medical Concepts to $4 From $2, Maintains Hold Rating"}], "updated_at": "2026-07-16T14:31:06.236107+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}